Cancer News and Research

Latest Cancer News and Research

Researchers have a promising lead on COVID-19 treatment

By taking a lesson from prostate cancer, researchers now have a promising lead on treatment for COVID-19. Two proteins, ACE2 and TMPRSS2, help the coronavirus gain entry and replicate within cells. TMPRSS2 is well-known to Arul Chinnaiyan, M.D., Ph.D. His lab discovered that TMPRSS2 fuses with the ETS gene to drive more than half of all prostate cancers. They also knew that TMPRSS2 was regulated by the androgen receptor.

21 Dec 2020

A real-time platform for monitoring microvascular health of COVID-19 patients in ICUs

As COVID-19 spread worldwide in early 2020, the avalanche of patients requiring admission into intensive care units (ICUs) suddenly became overwhelming to the healthcare systems.

21 Dec 2020

Study highlights the far-reaching effects of mutagenic compounds on human health

In order to survive, flourish and successfully reproduce, organisms rely on a high degree of genetic stability. Mutagenic agents, which can threaten the integrity of the genetic code by causing mutations in DNA, pose a serious risk to human health.

21 Dec 2020

Absence of anti-tumor protein may cause resistance to EGFR-targeting therapies

The absence of a protein that works to prevent tumor formation may explain why some patients are resistant to a common cancer therapy, according to Penn State College of Medicine researchers.

21 Dec 2020

The weak spot of colon cancer stem cells

Colon cancer stem cells have one weak spot: the enzyme Mll1. An MDC team led by Walter Birchmeier has now shown in Nature Communications that blocking this protein prevents the development of new tumors in the body.

21 Dec 2020

First patient enrolled in Phase II clinical trial of stem cell therapy for traumatic injuries

The first patient has enrolled in a Phase II clinical trial evaluating a stem cell therapy for the potential early treatment of traumatic injuries and their subsequent complications at The University of Texas Health Science Center at Houston.

21 Dec 2020

Stem cell engineering used to identify gene signaling pathway linked to schizophrenia

Using human-induced pluripotent stem cells engineered from a single family's blood samples, a gene signaling pathway linked to a higher risk for developing schizophrenia was discovered by scientists at The University of Texas Health Science Center at Houston.

21 Dec 2020

Moffitt study may lead to potential treatment options for cutaneous T cell lymphoma

Cutaneous T cell lymphomas (CTCLs) are a group of non-Hodgkin lymphomas that develop from T cells and mainly impact the skin with painful lesions.

21 Dec 2020

Virtual telehealth platform enables kidney transplant evaluation from home

A virtual telehealth platform is allowing the surgery program at the Medical University of South Carolina to evaluate and wait-list patients for kidney transplantation despite reductions in direct, in-person health care visits brought about by the Coronavirus Disease 2019 (COVID-19) pandemic.

21 Dec 2020

Arthritis drug may be effective in treating immunotherapy-related heart complication

A drug typically prescribed for rheumatoid arthritis may also be effective in treating a rare but potentially deadly heart complication some cancer patients experience after taking immunotherapies, according to a study published in Cancer Discovery and co-led by investigators at Vanderbilt University Medical Center.

21 Dec 2020

Smartphone fitness apps and wearable activity trackers boost physical activity levels

A new study supports the efficacy of smartphone fitness apps and wearable activity trackers at elevating levels of physical activity.

21 Dec 2020

New report addresses the recovery of surgical services in post-pandemic

In 2013, the National Institute for Health Research (NIHR) established the GlobalSurg Collaborative, a network that has since grown to include more than 5,000 practicing surgeons from all corners of the planet.

21 Dec 2020

Study provides key data on safety of head and neck cancer surgery during COVID-19 pandemic

A recent international observational study provides important data on the safety of head and neck cancer surgery during the COVID-19 pandemic.

21 Dec 2020

Study: Exposure to metals may disrupt a woman's hormones during pregnancy

Exposure to metals such as nickel, arsenic, cobalt and lead may disrupt a woman's hormones during pregnancy, according to a Rutgers study.

21 Dec 2020

New understanding of physical properties of chromatin may show how genome is encoded and decoded

University of Alberta researchers have found an answer to a fundamental question in genomic biology that has eluded scientists since the discovery of DNA: Within the nucleus of our cells, is the complex package of DNA and proteins called chromatin a solid or a liquid?

20 Dec 2020

Study identifies biomarker gene signature that indicates potential liver toxicity

When agrochemical and pharmaceutical companies develop new products, they must test extensively for potential toxicity before obtaining regulatory approval. This testing usually involves lengthy and expensive animal studies.

18 Dec 2020

IU researchers receive $2.9 million grant to expand work on subconcussive impacts

Every year, nearly 2.5 million U.S. high school athletes participate in contact sports. Each of these athletes sustains an average of 650 subconcussive head impacts in a single season, hits that can negatively affect brain health.

18 Dec 2020

FDA approves first adjuvant treatment for patients with non-small cell lung cancer

Today, the U.S. Food and Drug Administration approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation.

18 Dec 2020

FDA approves first implant system for adults who have above-the-knee amputations

The U.S. Food and Drug Administration today approved the Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System, the first implant system marketed in the U.S. for adults who have transfemoral—or above-the-knee—amputations and who have or are anticipated to have rehabilitation problems with, or cannot use, a conventional socket prosthesis.

18 Dec 2020

FDA approves first oral drug for treating adult patients with advanced prostate cancer

Today, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer.

18 Dec 2020

Cancer News and Research

Latest Cancer News and Research

Researchers have a promising lead on COVID-19 treatment

A real-time platform for monitoring microvascular health of COVID-19 patients in ICUs

Study highlights the far-reaching effects of mutagenic compounds on human health

Absence of anti-tumor protein may cause resistance to EGFR-targeting therapies

The weak spot of colon cancer stem cells

First patient enrolled in Phase II clinical trial of stem cell therapy for traumatic injuries

Stem cell engineering used to identify gene signaling pathway linked to schizophrenia

Moffitt study may lead to potential treatment options for cutaneous T cell lymphoma

Virtual telehealth platform enables kidney transplant evaluation from home

Arthritis drug may be effective in treating immunotherapy-related heart complication

Smartphone fitness apps and wearable activity trackers boost physical activity levels

New report addresses the recovery of surgical services in post-pandemic

Study provides key data on safety of head and neck cancer surgery during COVID-19 pandemic

Study: Exposure to metals may disrupt a woman's hormones during pregnancy

New understanding of physical properties of chromatin may show how genome is encoded and decoded

Study identifies biomarker gene signature that indicates potential liver toxicity

IU researchers receive $2.9 million grant to expand work on subconcussive impacts

FDA approves first adjuvant treatment for patients with non-small cell lung cancer

FDA approves first implant system for adults who have above-the-knee amputations

FDA approves first oral drug for treating adult patients with advanced prostate cancer

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in